Search results
Author(s):
Nadja Scherbakov
,
Wolfram Doehner
Added:
3 years ago
Heart failure (HF) is a complex clinical syndrome with more than 15 million diagnosed cases worldwide.1,2 Characterised by structural or functional impairment of ventricular filling or ejection fraction (EF)3, HF is frequently accompanied by multiple comorbidities. Brain disorders, including stroke, mental disturbances and cognitive impairment are distinct from the comorbidities traditionally…
View more
Author(s):
Tomaz Podlesnikar
,
Victoria Delgado
,
Jeroen J Bax
Added:
3 years ago
Heart failure (HF) is a rapidly growing public health problem with an estimated prevalence of more than 26 million people worldwide.1 In developed countries the prevalence is 1–2% peaking at ≥10% among people aged over 70 years.2 In the US, the lifetime risk of developing HF is 20% among people aged 40 years or older.3 Diagnosing the underlying cause of HF is central to the choice of appropriate…
View more
Heart Failure 2024
Start date:
May 11, 2024
End date:
May 14, 2024
Event
Heart Failure 2023
Start date:
May 20, 2023
End date:
May 23, 2023
Event
Heart Rhythm Society (HRS)
Supplier
Author(s):
Peter Hanna
,
Kalyanam Shivkumar
,
Jeffrey L Ardell
Added:
3 years ago
Heart failure (HF) is associated with significant morbidity and mortality, and the burden of disease is rising.1 Despite improved survival – partly a result of advances in medical therapy, coronary interventions and ICD – the mortality rate remains high and relatively stagnant.2 Moreover, advanced HF is associated with impaired quality of life (QOL), which is reflected in the significant number…
View more
Author(s):
Fraser J Graham
,
Antonio Iaconelli
,
Piotr Sonecki
,
et al
Added:
10 months ago
Author(s):
Aniket S Rali
,
Jonathan Menachem
Added:
3 years ago
In this video discussion, Dr Aniket Rali, an editorial board member for CFR journal, meets with Dr Jonathan Menachem (Vanderbilt University, TN, US), director of advanced cardiac therapies for congenital patients, to discuss issues surrounding adult congenital heart disease (ACHD) and heart failure (HF). Hear them discuss his unique skill set, having experience in both transplant cardiology and…
View more
Start date:
Apr 30, 2017
Live stream of Novartis sponsored symposium
©2017 Novartis Pharma AG, CH-4002 Basel –
March 2017 – GLCM/HTF/0408
Sunday 30 April: Satellite Symposium →
Sunday 30 April: Experts on the Spot →
Please note this content is not intended for
healthcare professionals licensed in the USA Please use Internet Explorer or
Firefox browser to view the Live Stream -->
Contemporary management…
View more
Author(s):
Marco Metra
,
Elisabetta Dinatolo
,
Nicolò Dasseni
Added:
3 years ago
Despite improvements in treatment, heart failure (HF) continues to have a progressive clinical course characterised by worsening of cardiac function and clinical condition, leading to a stage of advanced chronic HF. At this stage, the clinical picture is characterised by severe symptoms, frequent episodes of decompensation, poor quality of life and poor survival. Evidence-based medical treatments…
View more